Abstract:The yeast Saccharomyces cerevisiae contains two genes, PDE1 and PDE2, which respectively encode a low-affinity and a high-affinity cAMP phosphodiesterase. The physiological function of the low-affinity enzyme Pde1 is unclear. We show that deletion of PDE1, but not PDE2, results in a much higher cAMP accumulation upon addition of glucose or upon intracellular acidification. Overexpression of PDE1, but not PDE2, abolished the agonist-induced cAMP increases. These results indicate a specific role for Pde1 in controlling glucose and intracellular acidification-induced cAMP signaling. Elimination of a putative protein kinase A (PKA) phosphorylation site by mutagenesis of serine252 into alanine resulted in a Pde1(ala252) allele that apparently had reduced activity in vivo. Its presence in a wild-type strain partially enhanced the agonist-induced cAMP increases compared with pde1Delta. The difference between the Pde1(ala252) allele and wild-type Pde1 was strongly dependent on PKA activity. In a RAS2(val19) pde2Delta background, the Pde1(ala252) allele caused nearly the same hyperaccumulation of cAMP as pde1Delta, while its expression in a PKA-attenuated strain caused the same reduction in cAMP hyperaccumulation as wild-type Pde1. These results suggest that serine252 might be the first target site for feedback inhibition of cAMP accumulation by PKA. We show that Pde1 is rapidly phosphorylated in vivo upon addition of glucose to glycerol-grown cells, and this activation is absent in the Pde1(ala252) mutant. Pde1 belongs to a separate class of phosphodiesterases and is the first member shown to be phosphorylated. However, in vitro the Pde1(ala252) enzyme had the same catalytic activity as wild-type Pde1, both in crude extracts and after extensive purification. This indicates that the effects of the S252A mutation are not caused by simple inactivation of the enzyme. In vitro phosphorylation of Pde1 resulted in a modest and variable increase in activity, but only in crude extracts. This was absent in Pde1(ala252), and phosphate incorporation was strongly reduced. Apparently, phosphorylation of Pde1 does not change its intrinsic activity or affinity for cAMP but appears to be important in vivo for protein-protein interaction or for targeting Pde1 to a specific subcellular location. The PKA recognition site is conserved in the corresponding region of the Schizosaccharomyces pombe and Candida albicans Pde1 homologues, possibly indicating a similar control by phosphorylation.

Identification and characterisation of a human calmodulin-stimulated phosphodiesterase PDE1B1

A novel cyclic GMP stimulated phosphodiesterase from rat brain.

Genomic structure and chromosome location of the murine PDE1B phosphodiesterase gene

Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae

The Full-Length Cdna Cloning and Expression Profiles of 14-3-3 Genes from the Mud Crab Scylla Paramamosain Estampador, 1949

Differential amplification of intron-containing transcripts reveals long term potentiation-associated up-regulation of specific Pde10A phosphodiesterase splice variants.

Molecular Cloning of a Cdna for the Human Inositol 1,4,5-Trisphosphate Receptor Type 1, and the Identification of a Third Alternatively Spliced Variant.

Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is regulated by cAMP-dependent protein kinase.

Molecular Cloning and Characterization of a Novel Human Protein Phosphatase, LMW-DSP3

Identification of Alternative Splicing Variants of the Beta Subunit of Human Ca(2+)/calmodulin-dependent Protein Kinase II with Different Activities.

Assays for Cyclic Nucleotide‐Specific Phosphodiesterases (PDEs) in the Central Nervous System (PDE1, PDE2, PDE4, and PDE10)

Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities

Determination of Ca2+/calmodulin-stimulated phosphodiesterase activity in intact cells.

Identification and Characterization of Phosphodiesterases That Specifically Degrade 3′3′-Cyclic GMP-AMP

Molecular Cloning and Characterization of a Novel Human Gene (HSPBAP1) from Human Fetal Brain

Molecular Cloning and Characterization of A Novel Dual-Specificity Phosphatase 23 Gene from Human Fetal Brain

Identification and characterization of phosphodiesterases that specifically degrade 3’3’-cyclic GMP-AMP (INM2P.358)

TcrPDEA1, a cAMP-specific phosphodiesterase with atypical pharmacological properties from Trypanosoma cruzi

Molecular Cloning and Characterization of a Novel Dual-Specificity Phosphatase18 Gene from Human Fetal Brain.

The PDE1-encoded low-affinity phosphodiesterase in the yeast Saccharomyces cerevisiae has a specific function in controlling agonist-induced cAMP signaling.

Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta